• Accueil >
  • Publications >
  • Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial

Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial

1 juin 2015The Lancet Haematology

DOI : 10.1016/s2352-3026(15)00074-5

Auteurs

Antonio Omuro, Olivier Chinot, Luc Taillandier, Hervé Ghesquieres, Carole Soussain, Vincent Delwail, Thierry Lamy, Rémy Gressin, Sylvain Choquet, Pierre Soubeyran, Aymeri Huchet, Alexandra Benouaich-Amiel, Sophie Lebouvier-Sadot, Emmanuel Gyan, Valérie Touitou, Maryline Barrié, Monica Sierra del Rio, Alberto Gonzalez-Aguilar, Caroline Houillier, Daniel Delgadillo, Lucette Lacomblez, Marie Laure Tanguy, Khê Hoang-Xuan